Clinical Trials Directory

Trials / Unknown

UnknownNCT05613855

Performance of Pulmonary Embolism Risk Scores Out Come in CTPA Confirmed Patients

Performance of Pulmonary Embolism Risk Scores for Assessment of Outcome in Computed Tomographic Pulmonary Angiography Confirmed Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

1. Assess performance of PERFORM score in predicting outcome in CTPA confirmed patients. 2. Compare PERFORM score with the currently validated PESI in risk stratification of patients

Detailed description

Pulmonary embolism (PE) is a common and potentially lethal condition in the emergency department requiring early and accurate management. The short-term mortality rate of PE varies widely and ranges from less than 2% in many patients with non massive PE to more than 95% in patients who experience cardiorespiratory arrest. Although several prognostic models of acute PE are currently used, all of them have practical limitations. Of all clinical scores integrating PE severity and comorbidity, the Pulmonary Embolism Severity Index (PESI) and its simplified version,(sPESI) have been most extensively validated to date. However, current prognostic scores for pulmonary embolism (PE) are partly based on patients without PE confirmation via computed tomographic pulmonary angiography (CTPA), involving subjective parameters and complicated scoring methods \[8\]. Therefore, an objective, accurate, and simple prognostic model in CTPA-confirmed patients to predict the risk of 30-day mortality. help clinicians assess patients' risks and improve therapeutic decision-making that is called PERFORM score (pulmonary embolism risk score for mortality)

Conditions

Timeline

Start date
2022-11-01
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2022-11-14
Last updated
2022-11-14

Source: ClinicalTrials.gov record NCT05613855. Inclusion in this directory is not an endorsement.